TCI Wealth Advisors, Inc. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$19,000
+111.1%
2780.0%0.00%
+200.0%
Q2 2022$9,000
+28.6%
278
+36.3%
0.00%0.0%
Q1 2022$7,000
+133.3%
204
+70.0%
0.00%
Q3 2021$3,000
-50.0%
120
+20.0%
0.00%
-100.0%
Q3 2020$6,0000.0%1000.0%0.00%
-33.3%
Q2 2020$6,000
+20.0%
1000.0%0.00%
+50.0%
Q1 2020$5,000
-37.5%
1000.0%0.00%
-33.3%
Q4 2019$8,0001000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders